CAI
Caris Life Sciences, Inc. Common Stock
SERVICES-MEDICAL LABORATORIES
Best Medical Labs Stocks 2026 →
Caris Life Sciences (CAI) Stock: Buy, Sell, or Hold?
$24.43
-1.14 (-4.46%)
▼
5d:
-25.63%
30d:
-17.72%
90d:
+9.75%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (56%)
Quality Score
56/100
Position
OVERSOLD
30-Day Fair Range
$27.40 – $33.43
Position: OVERSOLD
Forward P/E & Valuation
66.3x
FAIR
vs 58.3x historical avg
Wall Street Target
$34.00
+39.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$23.90 / $36.50
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: CAI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When CAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.93
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.13
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAI is currently trading at $24.43, which is considered oversold relative to its 30-day fair value range of $27.40 to $33.43. From a valuation perspective, the stock is trading at a premium (Forward PE: 66.3) compared to its historical average (58.3). At these levels, the market is pricing in 4.4% annual earnings growth.
Technical Outlook: Technically, CAI is in a strong uptrend. The price is currently testing key support at $23.90. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: CAI scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $34.00 (+39.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CAI is in a strong uptrend. The price is currently testing key support at $23.90. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: CAI scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $34.00 (+39.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$27.40 -
$33.43
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.7%
Trading Range & Key Levels
30-Day Trading Range
$27.40 -
$33.43
Current vs Trading Range
OVERSOLD
Support Level
$23.90
Resistance Level
$36.50
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.5%)
- BULLISH: Trading 39.2% below Wall St target ($34.00)
- BULLISH: Expecting earnings turnaround to 4.4% growth with 27.0% revenue growth
- CAUTION: 5-day price weakness (-25.6%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
66.33
Wall Street Target
$34.00
(+39.2%)
Revenue Growth (YoY)
27.0%
Earnings Growth (YoY)
-37.5%
Profit Margin
9.2%
Valuation Premium vs History
+4.4% premium
PE vs Historical
66.3 vs 58.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.4%
(market-implied from PE analysis)
1-Year Target
$25.50
(+4%)
2-Year Target
$26.63
(+9%)
3-Year Target
$27.80
(+14%)
3-Yr Target (if PE normalizes)
(PE: 66→58)
PE COMPRESSION
$24.43
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 66.3, Growth: 219.2%)
$82.45
(+238%)
Base:
(SPY PE: 19.9, Growth: 219.2%)
$24.69
(+1%)
Bear:
(PE: 16.9, Growth: 219.2%)
$20.98
(-14%)
📈
Valuation based on Current Earnings
Trailing PE: 15.40 | Current EPS (TTM): $1.66
Bull Case
$14.06
(-42%)
Analyst growth -50.0%, PE expands to 16.9
Base Case
$12.78
(-48%)
Market implied -50.0%, PE stable at 15.4
Bear Case
$17.39
(-29%)
Severe decline -20.0%, PE contracts to 13.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share CAI Analysis
Share this live CAI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CAI)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment dominates on StockTwits regarding $CAI with no positive news to offset.
Key Retail Themes:
bearish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:52 AM ET
Data refreshes hourly during market hours. Next update: 9:52 AM
Data refreshes hourly during market hours. Next update: 9:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 49 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CAI Research Pages